These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28214655)

  • 1. Identification of microRNA biomarkers for response of advanced soft tissue sarcomas to eribulin: Translational results of the EORTC 62052 trial.
    Wiemer EAC; Wozniak A; Burger H; Smid M; Floris G; Nzokirantevye A; Sciot R; Sleijfer S; Schöffski P
    Eur J Cancer; 2017 Apr; 75():33-40. PubMed ID: 28214655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.
    Schöffski P; Ray-Coquard IL; Cioffi A; Bui NB; Bauer S; Hartmann JT; Krarup-Hansen A; Grünwald V; Sciot R; Dumez H; Blay JY; Le Cesne A; Wanders J; Hayward C; Marreaud S; Ouali M; Hohenberger P;
    Lancet Oncol; 2011 Oct; 12(11):1045-52. PubMed ID: 21937277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.
    Schöffski P; Chawla S; Maki RG; Italiano A; Gelderblom H; Choy E; Grignani G; Camargo V; Bauer S; Rha SY; Blay JY; Hohenberger P; D'Adamo D; Guo M; Chmielowski B; Le Cesne A; Demetri GD; Patel SR
    Lancet; 2016 Apr; 387(10028):1629-37. PubMed ID: 26874885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma.
    Kawai A; Araki N; Naito Y; Ozaki T; Sugiura H; Yazawa Y; Morioka H; Matsumine A; Saito K; Asami S; Isu K
    Jpn J Clin Oncol; 2017 Feb; 47(2):137-144. PubMed ID: 28173193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study.
    Nakamura T; Tsukushi S; Asanuma K; Katagiri H; Ikuta K; Nagano A; Kozawa E; Yamada S; Shido Y; Yamada K; Kawanami K; Ishimura D; Sudo A; Nishida Y
    Clin Exp Metastasis; 2019 Aug; 36(4):343-350. PubMed ID: 31209624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes.
    Kobayashi E; Naito Y; Asano N; Maejima A; Endo M; Takahashi S; Megumi Y; Kawai A
    Jpn J Clin Oncol; 2019 Oct; 49(10):938-946. PubMed ID: 31365116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eribulin therapy for the treatment of patients with advanced soft tissue sarcoma.
    Seetharam M; Kolla KR; Chawla SP
    Future Oncol; 2018 Jul; 14(16):1531-1545. PubMed ID: 29411654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eribulin in advanced liposarcoma and leiomyosarcoma.
    Setola E; Noujaim J; Benson C; Chawla S; Palmerini E; Jones RL
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):717-723. PubMed ID: 28621163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Biomarkers of Response to Eribulin in Patients with Leiomyosarcoma.
    Wozniak A; Boeckx B; Modave E; Weaver A; Lambrechts D; Littlefield BA; Schöffski P
    Clin Cancer Res; 2021 Jun; 27(11):3106-3115. PubMed ID: 33795257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of eribulin mesylate for the treatment of metastatic soft tissue sarcoma.
    Emambux S; Italiano A
    Expert Opin Pharmacother; 2017 Jun; 18(8):819-824. PubMed ID: 28468516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eribulin in soft-tissue sarcoma.
    Young RJ; Woll PJ
    Lancet; 2016 Apr; 387(10028):1594-6. PubMed ID: 26874886
    [No Abstract]   [Full Text] [Related]  

  • 12. Sarcoma: Eribulin--a welcomed advance.
    Romero D
    Nat Rev Clin Oncol; 2016 Apr; 13(4):204. PubMed ID: 26925959
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma.
    Sato Y; Nakano K; Fukuda N; Wang X; Urasaki T; Ohmoto A; Yunokawa M; Ono M; Tomomatsu J; Hayakawa K; Funauchi Y; Tanizawa T; Ae K; Matsumoto S; Takahashi S
    Anticancer Res; 2021 Jan; 41(1):527-532. PubMed ID: 33419852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas.
    López-Álvarez M; González-Aguilera C; Moura DS; Sánchez-Bustos P; Mondaza-Hernández JL; Martín-Ruiz M; Renshaw M; Ramos R; Castilla C; Blanco-Alcaina E; Hindi N; Martín-Broto J
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.
    Haddox CL; Nathenson MJ; Mazzola E; Lin JR; Baginska J; Nau A; Weirather JL; Choy E; Marino-Enriquez A; Morgan JA; Cote GM; Merriam P; Wagner AJ; Sorger PK; Santagata S; George S
    Clin Cancer Res; 2024 Apr; 30(7):1281-1292. PubMed ID: 38236580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin.
    Inagaki C; Shimoi T; Okuma H; Kitano A; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Yoshida A; Fujiwara Y; Tamura K
    Anticancer Drugs; 2018 Jan; 29(1):97-101. PubMed ID: 29176397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eribulin Shows Promise in Advanced Sarcoma.
    Cancer Discov; 2015 Jul; 5(7):OF4. PubMed ID: 26045011
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
    De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A
    Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and Implications of New Biomarkers.
    Nakamura H; Takada K; Emori M; Hayasaka N; Sugita S
    Intern Med; 2022 Dec; 61(23):3617-3621. PubMed ID: 35527027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.
    Demetri GD; Schöffski P; Grignani G; Blay JY; Maki RG; Van Tine BA; Alcindor T; Jones RL; D'Adamo DR; Guo M; Chawla S
    J Clin Oncol; 2017 Oct; 35(30):3433-3439. PubMed ID: 28854066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.